Longitudinal Health Insurance Data AIM The aim of the study was to investigate the risk of stroke in patients with cerebral palsy (CP), based on nationwide data in Taiwan. RESULTS Patients with CP were more likely to suffer stroke than the comparison population, after adjusting for potential confounding factors (adjusted hazard ratio: 2.17; 95% confidence interval [CI]: 1.74-2.69). The hazard ratio of stroke was 4.78 (95% CI: 3.18-7.17) and 1.57 (95% CI: 1.20-2.05) for patients with CP aged 50 years and under, and over 50 years respectively.
RESULTS
Patients with CP were more likely to suffer stroke than the comparison population, after adjusting for potential confounding factors (adjusted hazard ratio: 2.17; 95% confidence interval [CI]: 1.74-2.69). The hazard ratio of stroke was 4.78 (95% CI: 3.18-7.17) and 1.57 (95% CI: 1.20-2.05) for patients with CP aged 50 years and under, and over 50 years respectively.
INTERPRETATION Cerebral palsy is a risk factor or marker for stroke that is independent of traditional stroke risk factors. Further research in this area is warranted.
Cerebral palsy (CP) is defined as a group of permanent disorders of the development of movement and posture, which causes activity limitation, and is attributed to nonprogressive disturbances that occur in the developing fetal or infant brain. 1 Clinical manifestations include motor deficits, perceptive disturbances, cognitive impairment, and behavioural and emotional disorders. 1 A common classification is based on abnormal muscle tone, including spastic, dyskinetic, and ataxic types. 1 The worldwide prevalence of CP is 2.0 to 2.5 per 1000 live births. 2 The precise aetiology of CP remains unknown, but preterm birth is considered to be a major risk factor. 3 Cerebral palsy can be a severe neurological disability that disturbs movement, posture, neuromuscular control, and often results in dysphagia, epilepsy, and osteoporosis.
According to the latest data released by the Center for Disease Control and Prevention's National Center for Health Statistics, stroke was the fourth leading cause of death in the United States in 2008. In Taiwan, stroke was the third major cause of death in 2010, and accounted for 7% of total deaths that year. It places an enormous cost and burden on Taiwan's national health care system. 4 One community-based Taiwanese cohort study reported that the incidence of stroke for people aged over 35 years was 3.32 per 1000 for males and 4.67 per 1000 for females. 5 There are well-known risk factors for stroke such as hypertension, diabetes, hyperlipidaemia, smoking, obesity, and urbanization level. 6 Some evidence supports the theory that inflammation and chronic infection may also play an essential role in stroke. 7 A previous study showed that the death rates for cerebrovascular disease were three times as high in the CP population compared with the general population. 8 Studies regarding the relationship between CP and stroke have not yet been explored thoroughly. To our knowledge, no previous study with large patient samples has been conducted to evaluate the risk of stroke in patients with CP. The purpose of the current study was to assess the hypothesis that CP is a risk factor for stroke by using a large-scale nationwide Taiwanese database.
METHOD Study participants and design
This is a prospective matched cohort study. By examining the identification numbers of the 11 850 patients year by year between 2004 and 2008, we found 208 individuals no longer exist in the LHID2005 and all of them happened to be without stroke. They were noted as censored observations. The cause of loss follow-up could be death, emigration from Taiwan, return to country of origin for resident aliens in Taiwan, cancellation of insurance, and so on.
Endpoint of the study and measured variables
The data for each patient were followed from the entry date until the development of stroke (ICD-9-CM codes 430-438) or until 31 December 2008, whichever occurred first. For those 208 individuals lost to follow-up, the endpoint of the study was the date of last known presence in the LHID2005. For all patients in both cohorts, data regarding comorbid diseases were obtained according to ICD-9 coding guidelines. The observed comorbid diseases included renal disease, diabetes mellitus, hypertension, hyperlipidaemia, coronary heart disease, and chronic liver disease. The demographic characteristics included age, sex, and urbanization level.
Statistical analysis
Group differences in characteristics and co-medical disorders were evaluated by Pearson's v 2 test or Fisher's exact test. Cox proportional-hazards regression was used to compare hazard rates for stroke between the study cohort and the comparison cohort after adjusting for potential confounding factors, including age (as a continuous variable), sex, diabetes mellitus, coronary heart disease, hypertension, hyperlipidaemia, chronic liver disease, and urbanization level. Each dichotomous variable in the model was checked for proportionality by exploratory diagnostic log-log survival plots to meet the proportional-hazards assumption.
The stroke hazard rate curves based on the Kaplan-Meier method were plotted for the patients with CP and the comparison cohort. All analyses were performed using the SAS statistical package (SAS System for Windows, version 9.1.3; SAS Institute Inc., Cary, NC, USA) and IBM SPSS (version 20; IBM Corp., Armonk, NY, USA). A two-tailed p value<0.050 was considered statistically significant.
RESULTS
The initial baseline characteristics between the CP and comparison cohorts are shown in Table I . Patients with CP had higher rates of comorbid chronic liver disease (p=0.041) than those in the comparison cohort. There were no statistical differences in other comorbid diseases.
As shown in Table II , of the 1975 patients with CP, 111 (a rate of 164 per 10 000 person-years) were diagnosed with stroke during the 6750 person-year follow-up period. Of the 9875 comparison patients, 332 (a rate of 80 per 10 000 person-years) were diagnosed with stroke during the 41 377 person-year follow-up period. In Cox What this paper adds
• Cerebral palsy (CP) is a risk factor for stroke.
• CP presents a 2.17-fold greater risk for stroke than the general population.
regression analysis, the stroke hazard ratio during the follow-up period was 2.04 (95% confidence interval [CI]: 1.64-2.53) for patients with CP. Similarly, after adjusting for patient age, sex, urbanization level, diabetes mellitus, hypertension, coronary heart disease, hyperlipidaemia, and chronic liver disease, the adjusted stroke hazard ratio was 2.17 (95% CI: 1.74-2.69) times greater for patients with CP compared with the comparison cohort. The hazard curves were calculated using the nonparametric KaplanMeier method for stroke in the CP and comparison cohorts during the follow-up period of 5 years (Fig. 1) .
As shown in Table III , we further analyzed the hazard ratio of stroke stratified by age. We found that compared with patients in the comparison cohort, the hazard ratios for ages 50 years or less and greater than 50 years were respectively, 4.78 (95% CI: 3.18-7.17, p<0.001) and 1.57 (95% CI: 1.20-2.05, p<0.050), after adjusting for other potential confounders. In addition, we found that although the stroke incidence in ages greater than 50 years is higher than in ages 50 years or less (357 per 10 000 person-years vs 89 per 10 000 person-years), the adjusted hazard ratio for the two groups (50y vs >50y) was statistically different, and patients with CP were more prone to stroke for ages 50 years or less than for ages greater than 50 years, compared with the comparison patients.
We also considered the interaction of comorbid hypertension, age, and CP. Figure 2 shows the hazard curves plotted using the nonparametric Kaplan-Meier method for stroke in the interactions between hypertension, age, CP, and the comparison cohort during the 5-year follow-up period.
DISCUSSION
This was the first nationwide study to demonstrate the risk of stroke after a diagnosis of CP. After adjusting for demographic characteristics and comorbid medical disorders, we found that the hazard ratio for stroke was significantly higher in patients with CP, irrespective of age and sex. A population-based study reported that the mortality rate of CP caused by cerebrovascular disease was 3.1 and 2.1 times higher at 35 to 54 years of age and over 55 years respectively, compared with an age-and sex-matched general Californian population. 8 Our findings are in agreement with that study.
The exact cause of stroke resulting from CP is not fully understood. We hypothesize several possible mechanisms. First, neurological impairment raises barriers to activity participation and mobility. Children with CP have been reported to have lower levels of activity than peers with typical development. 9 As children with CP grow older, the decline of physical activity continues or worsens. Day et al. 10 found that as many as 34% of children who walked and also used wheelchairs were at the greatest risk of losing their ambulatory ability at early adulthood. Opheim et al. 11 reported that 52% of patients with CP had deterioration in ambulation by 37 years of age, especially those with bilateral spasticity, fatigue, and pain. Moreover, reduced muscle volumes throughout the lower limbs, and failure to maximally recruit target muscles during voluntary activities, were documented to reduce gait and mobility efficiency, and increase energy expenditure and fatigue. 12, 13 In addition, physical inactivity combined with muscle dysfunction results in early sarcopenia. With muscle atrophy, insufficient muscle strength, and weakness, motor function deterioration and sedentary behaviour are inevitable. Long-term negative consequences such as a cerebrovascular disease from inactivity and a sedentary lifestyle are therefore more likely.
Second, the prevalence of obesity and overweight children with CP has increased, especially for ambulatory children at Gross Motor Function Classification System levels I and II.
14 Although the prevalence of obesity in adults with CP has not been documented, studies have identified greater intermuscular adipose tissue and greater trunk adiposity than healthy adults. 15 Because the body mass index does not account for actual amounts of fat and muscle, it may not be an accurate representation of the degree of adiposity. 16 With the increase of fat mass and muscle atrophy, the patient with CP is likely to have a normal body mass index, yet still possess excess body fat or normal-weight obesity. 17 Another contributor to obesity in CP is the decline in energy metabolism. Several researchers have shown that the loss of fat-free mass was associated with the reduction of resting energy expenditure. 18 With physical inactivity, a diminished energy expenditure of physical activity, and positive energy balance, obesity in patients with CP is conceivable. 19 It is a circular relationship with changes in body composition, where increasing body fat and muscle atrophy further deteriorates mobility, increases disability, and predisposes patients with CP to limited participation and a sedentary lifestyle. With physical inactivity, muscle atrophy, changes in body composition, a decline in energy metabolism, and obesity, patients with CP are at increased risk of developing cerebrovascular disease.
Obesity stimulates a chronic inflammatory response. 20 Moreover, chronic inflammation in patients with CP may be linked to a prolonged neurological injury process. 3 One study suggested that increased inflammatory cytokines in the amniotic fluid are associated with CP in infants born preterm. 21 One study reported that the levels of tumour necrosis factor alpha and inflammatory molecule mRNA were significantly higher in children born preterm with CP when they reached school age. 22 Perinatal inflammation is associated with periventricular leukomalacia and CP. An inflammatory response that starts during the perinatal period may continue until childhood. Inflammation is currently accepted as a central factor in atherosclerosis, plaque rupture, thrombosis, and stroke. 23 Thus, chronic inflammation predisposes patients with CP to cerebrovascular accidents. Osteoporosis is a common secondary condition in patients with CP, and CP is the most prevalent condition in children with osteoporosis. 24 Aronow et al. 25 reported that an increased osteoprotegerin level in people with osteoporosis may be an indicator of a proinflammatory milieu and promote atherosclerosis such as ischaemic stroke.
As shown in Table III , compared with age-matched comparisons, patients with CP aged 50 years and under had a 4.78-fold greater risk of stroke, and patients with CP aged over 50 years had a 1.57-fold greater risk of stroke. This is probably because the general population is more prone to having a stroke over 50 years of age. Moreover, the proportion of more severe cases of CP diminishes with age. Life expectancies for adolescents and adults with CP are lower for those who are more severely disabled. 26 Considering the effect of traditional risk factors, Figure 2 shows that patients with CP with hypertension and aged over 50 years had a higher risk for stroke than the general population and all patients with CP. The result implied that the interaction between ageing and hypertension magnified the risk of stroke in patients with CP. Stroke prevention and risk monitoring should be raised as early as possible with patients with CP.
This study had limitations. First, risk factors such as a family history of stroke, body mass index, and smoking are not recorded in the National Health Insurance database. Because our study adjusted for other comorbid medical disorders related to body mass index and smoking, such as diabetes mellitus, hypertension, hyperlipidaemia, and coronary heart disease, the bias should be minimized. Second, the presentation of spastic hemiplegic-type CP and the side effect of antiepileptic or antispastic medication may mimic stroke. Thus, stroke would not be diagnosed precisely during the follow-up period. However, because the National Health Insurance database was set up for administrative billing and disease payment rather than scientific research purposes, CP type and severity were not enrolled. Moreover, we could not obtain information regarding medication. A future study including CP type and severity would be an important contribution.
Despite these limitations, we believe this study identified CP as an independent risk marker for stroke. Patients with CP have a higher risk of stroke, and interventions such as physical activity and therapeutic treatments for osteoporosis should be vital for stroke prevention strategies.
